FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2810309478> ?p ?o ?g. }

• W2810309478 endingPage "e0199553" @default.
• W2810309478 startingPage "e0199553" @default.
• W2810309478 abstract "There is no single standard chemotherapy regimen for elderly patients with advanced gastric cancer (AGC). A phase III trial has confirmed that both capecitabine monotherapy and capecitabine plus oxaliplatin are well tolerated for elderly patients with AGC, but their economic influence in China is unknown.The purpose of this cost-effectiveness analysis was to estimate the effects of capecitabine monotherapy and capecitabine plus oxaliplatin in elderly patients with AGC on health and economic outcomes in China.We created a Markov model based on data from a Korean clinical phase III trial to analyze the cost-effectiveness of the treatment of elderly patients in the capecitabine monotherapy (X) group and capecitabine plus oxaliplatin (XELOX) group. The costs were obtained from published reports and the local health system. The utilities were assumed on the basis of the published literature. Costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICER) were estimated. One-way and probabilistic sensitivity analyses (Monte Carlo simulations) were performed.In the cost-effectiveness analysis, X had a lower total cost ($45,731.68) and cost-effectiveness ratio ($65,918.93/QALY). The one-way sensitivity analysis suggested that the most influential parameter was the risk of requiring second-line chemotherapy in XELOX group. The probabilistic sensitivity analysis predicted that the X regimen was cost-effective 100% of the time, given a willingness-to-pay threshold of $26,598.Our findings show that the XELOX regimen is less cost-effective compared to the X regimen for elderly patients with AGC in China from a Chinese healthcare perspective." @default.
• W2810309478 created "2018-07-10" @default.
• W2810309478 creator A5015533842 @default.
• W2810309478 creator A5023174618 @default.
• W2810309478 creator A5023593290 @default.
• W2810309478 creator A5044687301 @default.
• W2810309478 date "2018-06-28" @default.
• W2810309478 modified "2023-09-24" @default.
• W2810309478 title "Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer" @default.
• W2810309478 cites W1548861910 @default.
• W2810309478 cites W1550663772 @default.
• W2810309478 cites W1568315148 @default.
• W2810309478 cites W1977373411 @default.
• W2810309478 cites W1980323844 @default.
• W2810309478 cites W2007093497 @default.
• W2810309478 cites W2007304396 @default.
• W2810309478 cites W2015966451 @default.
• W2810309478 cites W2025272463 @default.
• W2810309478 cites W2047783753 @default.
• W2810309478 cites W2114489245 @default.
• W2810309478 cites W2122866527 @default.
• W2810309478 cites W2127773543 @default.
• W2810309478 cites W2137210918 @default.
• W2810309478 cites W2142008486 @default.
• W2810309478 cites W2158527531 @default.
• W2810309478 cites W2219243155 @default.
• W2810309478 cites W2418334170 @default.
• W2810309478 cites W2515452405 @default.
• W2810309478 cites W2544785162 @default.
• W2810309478 cites W2556009055 @default.
• W2810309478 cites W2575186635 @default.
• W2810309478 cites W2917837889 @default.
• W2810309478 cites W4211007657 @default.
• W2810309478 doi "https://doi.org/10.1371/journal.pone.0199553" @default.
• W2810309478 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6023138" @default.
• W2810309478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29953476" @default.
• W2810309478 hasPublicationYear "2018" @default.
• W2810309478 type Work @default.
• W2810309478 sameAs 2810309478 @default.
• W2810309478 citedByCount "6" @default.
• W2810309478 countsByYear W28103094782019 @default.
• W2810309478 countsByYear W28103094782020 @default.
• W2810309478 countsByYear W28103094782022 @default.
• W2810309478 countsByYear W28103094782023 @default.
• W2810309478 crossrefType "journal-article" @default.
• W2810309478 hasAuthorship W2810309478A5015533842 @default.
• W2810309478 hasAuthorship W2810309478A5023174618 @default.
• W2810309478 hasAuthorship W2810309478A5023593290 @default.
• W2810309478 hasAuthorship W2810309478A5044687301 @default.
• W2810309478 hasBestOaLocation W28103094781 @default.
• W2810309478 hasConcept C112930515 @default.
• W2810309478 hasConcept C121608353 @default.
• W2810309478 hasConcept C126322002 @default.
• W2810309478 hasConcept C143998085 @default.
• W2810309478 hasConcept C2777909004 @default.
• W2810309478 hasConcept C2778336483 @default.
• W2810309478 hasConcept C2780962732 @default.
• W2810309478 hasConcept C2781413609 @default.
• W2810309478 hasConcept C3019080777 @default.
• W2810309478 hasConcept C515549039 @default.
• W2810309478 hasConcept C526805850 @default.
• W2810309478 hasConcept C64332521 @default.
• W2810309478 hasConcept C71924100 @default.
• W2810309478 hasConceptScore W2810309478C112930515 @default.
• W2810309478 hasConceptScore W2810309478C121608353 @default.
• W2810309478 hasConceptScore W2810309478C126322002 @default.
• W2810309478 hasConceptScore W2810309478C143998085 @default.
• W2810309478 hasConceptScore W2810309478C2777909004 @default.
• W2810309478 hasConceptScore W2810309478C2778336483 @default.
• W2810309478 hasConceptScore W2810309478C2780962732 @default.
• W2810309478 hasConceptScore W2810309478C2781413609 @default.
• W2810309478 hasConceptScore W2810309478C3019080777 @default.
• W2810309478 hasConceptScore W2810309478C515549039 @default.
• W2810309478 hasConceptScore W2810309478C526805850 @default.
• W2810309478 hasConceptScore W2810309478C64332521 @default.
• W2810309478 hasConceptScore W2810309478C71924100 @default.
• W2810309478 hasFunder F4320321001 @default.
• W2810309478 hasFunder F4320322843 @default.
• W2810309478 hasIssue "6" @default.
• W2810309478 hasLocation W28103094781 @default.
• W2810309478 hasLocation W28103094782 @default.
• W2810309478 hasLocation W28103094783 @default.
• W2810309478 hasLocation W28103094784 @default.
• W2810309478 hasLocation W28103094785 @default.
• W2810309478 hasOpenAccess W2810309478 @default.
• W2810309478 hasPrimaryLocation W28103094781 @default.
• W2810309478 hasRelatedWork W2041864477 @default.
• W2810309478 hasRelatedWork W2057477477 @default.
• W2810309478 hasRelatedWork W2347780995 @default.
• W2810309478 hasRelatedWork W2361031241 @default.
• W2810309478 hasRelatedWork W2418334170 @default.
• W2810309478 hasRelatedWork W2571282247 @default.
• W2810309478 hasRelatedWork W2805464686 @default.
• W2810309478 hasRelatedWork W2810309478 @default.
• W2810309478 hasRelatedWork W4206918075 @default.
• W2810309478 hasRelatedWork W4249475443 @default.
• W2810309478 hasVolume "13" @default.
• W2810309478 isParatext "false" @default.

• next